know your myeloma immunotherapy: teclistamab and other bispecifics
Published 11 months ago • 1.3K plays • Length 58:00Download video MP4
Download video MP3
Similar videos
-
57:20
know your myeloma immunotherapy: bispecific antibodies with dr. cesar rodriguez
-
14:31
teclistamab - guest lecture
-
57:49
know your myeloma therapy: what's available for maintenance therapy?
-
58:19
sequencing bcma myeloma therapies
-
2:33
teclistamab approval for multiple myeloma treatment | ross firestone, md, phd | asco 2023
-
56:40
immunotherapy 101 for multiple myeloma patients
-
7:40
results of bispecific antibody combination in advanced myeloma | yael cohen, md | asco 2023
-
9:57
teclistamab, a bcma × cd3 bispecific antibody, in pts with rrmm: updated phase 1 results
-
22:21
tecvayli (teclistamab) everything you need to know
-
1:00
multiple myeloma life expectancy
-
11:35
what are myeloma targets?
-
7:25
updated phase 1 results of teclistamab, a bcma × cd3 bispecific antibody, in rrmm
-
1:14:09
healthtree podcast for multiple myeloma: teclistamab's approval with dr. garfall
-
0:55
what are bispecific antibodies?
-
7:12
what are myeloma targets?
-
1:04:21
know your myeloma therapy: what's available for consolidation therapy?
-
1:27
risks of immunotherapy in myeloma?
-
1:00
multiple myeloma - signs and symptoms #myeloma #cancer
-
0:53
what is multiple myeloma?